Skip to main content

Peer Review reports

From: A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer

Original Submission
24 Feb 2010 Submitted Original manuscript
12 Aug 2010 Author responded Author comments - Vassilis Georgoulias
17 May 2010 Reviewed Reviewer Report - Hossein Borghaei
22 Jul 2010 Reviewed Reviewer Report - Shane WHite
Resubmission - Version 2
12 Aug 2010 Submitted Manuscript version 2
12 Nov 2010 Author responded Author comments - Vassilis Georgoulias
8 Sep 2010 Reviewed Reviewer Report - Hossein Borghaei
Resubmission - Version 3
12 Nov 2010 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
16 Nov 2010 Author responded Author comments - Vassilis Georgoulias
Resubmission - Version 5
16 Nov 2010 Submitted Manuscript version 5
Publishing
19 Nov 2010 Editorially accepted
19 Nov 2010 Article published 10.1186/1471-2407-10-633

You can find further information about peer review here.

Back to article page